Skip to main content
Google Tag Manager
P&T COMMUNITY
Register
Sign in
Search form
Search
News
Approvals, Launches, & New Indications
Pipeline Plus
Research News
Industry Trends
Safety Issues
Agency Actions
Health Care Reform
Guidelines
Clinical Trials
P&T
Current issue
Past issues
Contact us
Digital Edition
Subscribe
P&T TV
Dr. David B. Nash
Meeting Reports
Health Care & Law
Drug Forecast
More
Meeting Highlights
Medication Errors
Prescription: Washington
Authors
About
Contact Us
News
P&T Journal
Formulary Kits
INGREZZA®
(valbenazine) tablets
JAKAFI®
ruxolitinib (tablets)
KEDRAB™
(Rabies Immune Globulin [Human])
LOKELMA™
(sodium zirconium cyclosilicate) 10 g for oral suspension
PERSERIS™
(risperidone) for extended-release injectable suspension
ZULRESSO™
(brexanolone) injection CIV
You are here
Home
News by month %2 2007
News by month July 2007
PTCommunity News July 2007
FDA Requests Additional Data on Cardiovascular, Hepatic Effects for Desvenlafaxine
Safety Profile Confirmed in Phase 3 Trial of Iclaprim Complicated Skin Infections
FDA Approves First Molecular-Based Lab Test to Detect Metastatic Breast Cancer
Rotavirus, Papilloma Vaccines Adopted by CDC's Vaccines for Children Program
FDA Approves CustomVue Monovision LASIK
FDA Reviews Special Protocol Assessment for Forodesine Trial
Head-to-Head Phase 3 Trial Demonstrates Rivaroxaban's Superiority Over Enoxaparin
Disappointing Results Reported for Phase 3 Study of Tolevamer in Patients With Diarrhea
New Oseltamivir Doses Approved
Suicide Attempts Decline After Depression Treatment
